linaclotide 0.29 MG Oral Capsule [Linzess]

RxNorm concept 1307421, branded drug (sbd). Prescribable name: Linzess 290 MCG Oral Capsule.

RxCUI: 1307421
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1307421 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

linaclotide 1307404

Other names

Linzess 0.29 MG Oral Capsule; Linzess 290 MCG Oral Capsule

Related concepts

linaclotide 0.29 MG (SCDC, consists of)
linaclotide 0.29 MG [Linzess] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Linzess (BN, has ingredient)
linaclotide 0.29 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1307421 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1307421 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1307421. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.